Pressroom: Media Coverage

Showing 481 - 500 of 687 news items


Training Immune System to Fight Cancer Comes of Age

Medical oncologist Jedd Wolchok was interviewed about immunotherapy – the harnessing of the body’s immune system to fight cancer – and how it has turned certain cancers into chronic diseases for patients rather than fatal ones.

May 7, 2012
Gene Therapy Safe in Decade-Long HIV Study That May Widen Use

Michel Sadelain, Center for Cell Engineering Director, discussed encouraging findings of a recent study that found that HIV patients given gene therapy more than a decade ago are healthy and the altered DNA they received remains stable in their bodies. The study suggests that this treatment may safely be tested as a way to attack other illnesses.

May 2, 2012
Studies Reignite Mammography Debate For Middle-Aged Women

Diagnostic radiologist Carol Lee spoke about mammography for women in their 40s. Recent studies suggest that women with a low risk of breast cancer do not need regular mammograms until age 50, but Dr. Lee warns that the studies “may discourage women who don’t have an identifiable risk factor from seeking screening, and therefore the potential lifesaving benefit of screening won’t be realized.”

April 30, 2012
Do We "Waste" Money on Terminal Patients? (Part II)

Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes Peter Bach continued his discussion with American historian and broadcaster Richard Heffner about the cost of medical care.

April 28, 2012
What You Don't Know About Cancer

Human Oncology and Pathogenesis Program Chair Charles Sawyers spoke about the excitement around the emerging role of DNA in the fight against cancer. He said, “There has never been a time of greater optimism about the future of cancer therapy.”

April 23, 2012
Strides are Being Made in the Treatment of Neuroblastoma

Pediatric oncologist Shakeel Modak spoke about new treatments for neuroblastoma that are being pioneered by oncologists at Memorial Sloan Kettering.

April 23, 2012
Skin Cancer Prevention Tips

Dermatology Service Chief Allan Halpern offered skin cancer prevention tips and discussed sun safety with Martha Stewart and Debra Black of the Melanoma Research Alliance.

April 23, 2012
Do We "Waste" Money on Terminal Patients?

Director of Memorial Sloan Kettering’s Center for Health Policy and Outcomes Peter Bach discussed a recent essay he wrote in The New York Times about the amount of money spent on providing care to patients who may die.

April 21, 2012
Cancer Patients Suffer Unnecessary Pain

Pain and Palliative Care Service Chief Paul Glare commented on a study that found that as many as one-third of cancer patients may be receiving inadequate treatment to control their pain, even though many medicines are available to help.

April 19, 2012
Is Warren Buffett's Cancer Treatment Necessary?

Department of Surgery Chair Peter Scardino discussed prostate cancer diagnosis, screening, and treatment in light of Warren Buffet’s announcement that he will undergo radiation therapy for stage I prostate cancer.

April 18, 2012
How a Geiger Counter Helps Breast Cancer Patients

Breast Surgical Service Chief Monica Morrow was interviewed about the advantages of a new, more patient-friendly approach called radioactive seed localization, which is being used to locate and remove very small breast cancers that can only be seen by mammography.

April 18, 2012
The Push for Daily Sunscreen

Head of Memorial Sloan Kettering’s Basking Ridge Dermatology Section Steven Wang spoke about new FDA guidelines for sun-protection products, including cosmetics with sunscreen. The new guidelines state that products must pass a test to show they protect against both UVA and UVB rays and must clearly be labeled “broad spectrum” followed by an SPF number.

April 10, 2012
Can a Computer Diagnose, Treat Cancer?

Thoracic Oncology Service Chief Mark Kris spoke with CNN’s Erin Burnett about the collaboration between Memorial Sloan Kettering and IBM to develop a supercomputer to support oncologists based upon IBM’s Watson technology. He said, “The beautiful thing about Watson is that it extracts the information. It does not tell you an answer. It tells you the possible answers.”

April 9, 2012
When Supplements Become Dangerous

Herbalist and manager of Memorial Sloan Kettering’s About Herbs database K. Simon Yeung spoke about using dietary supplements to ease side effects of cancer treatment. He said that while some herbs help alleviate symptoms many can pose risks for people with cancer.

April 4, 2012
Interrupting Cancer's Travel Plans

Cancer Biology and Genetics Program Chair Joan Massagué discussed cancer metastasis. He said that while the silent nature of metastasis makes it a particularly daunting research subject, he’s optimistic that current research will yield treatments that extend patients’ lives.

April 1, 2012
Alec Guinness, Reluctant Intergalactic Icon

Medical oncologist Ghassan Abou-Alfa spoke about efforts to prevent and treat liver cancer 12 years after actor Alec Guinness’s death. He said that while liver cancer remains a frustrating disease, the past two decades have seen the emergence of new treatments. While only modestly successful, they do suggest a new approach to therapy.

April 1, 2012
Facing Your Challenges

Head and Neck Oncology Service Chief David Pfister spoke about quality of life after head and neck cancer. He said, “We are no longer satisfied with just cure and survival. We want to provide patients with optimal treatment to ‘beat’ their cancer while minimizing the side effects, both short and long term, from their therapy.”

April 1, 2012
Long-Term Estrogen Therapy Does Up Breast Cancer Risk

Deputy Physician-in-Chief for Breast Cancer Programs Larry Norton commented on a study that found that using estrogen-only hormone replacement therapy for ten years or more increases the long-term risk for breast cancer. Dr. Norton said he does not recommend that women take estrogen after menopause because “the jury is still out on how safe estrogen alone is.”

April 1, 2012
New Scanning Technology Might Help Guide Prostate Cancer Care

Memorial Sloan Kettering researcher Michael Evans reported on a new way to measure PSA, or prostate-specific antigen, a protein produced by cells of the prostate gland that can be an indication of prostate cancer. The new tool could provide a more accurate way to stage or monitor prostate cancer when compared with standard PSA screening tests.

March 31, 2012
HPV Vaccine May Prevent Recurrence of Precancerous Conditions

Gynecologic oncologist Ginger Gardner commented on a recent study that found that the HPV vaccine, in addition to preventing cervical cancer, may also prevent women diagnosed with precancerous conditions from developing recurrences. Dr. Gardner said the study is encouraging because there is currently no way to prevent the recurrence of these conditions, meaning clinicians must continually monitor them.

March 28, 2012